SCHEMBL657479

SCHEMBL657479

CCOC(=O)C(C(=O)O)C(CC(=O)c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 5/20 0.56
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
NPC1 O15118 1/20 0.52
POLB P06746 2/20 0.50
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
L3MBTL1 Q9Y468 4/20 0.47
MMP2 P08253 3/20 0.43
MMP3 P08254 3/20 0.43
MMP9 P14780 3/20 0.43
MMP13 P45452 2/20 0.43
MMP1 P03956 1/20 0.43
MMP8 P22894 1/20 0.43
MAPT P10636 2/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656693 0.95 KMT2A (0.55) PDPK1KMT2AMEN1NPC1POLB
SCHEMBL657931 0.88 MAPT (0.48) PDPK1KMT2AMEN1NPC1POLB
SCHEMBL657267 0.88 L3MBTL1 (0.56) PDPK1KMT2AMEN1NPC1POLB
SCHEMBL658265 0.86 PDPK1 (0.72) PDPK1KMT2AMEN1POLBCYP2C9
SCHEMBL7109210 0.85 KMT2A (0.67) PDPK1KMT2AMEN1NPC1POLB
SCHEMBL656131 0.82 PDPK1 (0.52) PDPK1KMT2AMEN1NPC1POLB
SCHEMBL658879 0.82 KMT2A (0.55) PDPK1KMT2AMEN1NPC1MMP8
SCHEMBL657882 0.82 NPC1 (0.55) PDPK1KMT2AMEN1NPC1POLB
SCHEMBL7107026 0.81 KMT2A (0.61) PDPK1KMT2AMEN1NPC1POLB
SCHEMBL658260 0.81 KMT2A (0.52) PDPK1KMT2AMEN1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO claimed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP claimed
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB PDPK1 109/4885KMT2A 1777/4885MEN1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.